Table 3.
Variables | Day | Silymarin | Placebo | P-value |
---|---|---|---|---|
MDA | Baseline | 0.76 ±0.72 | 0.76 ±0.95 | 0.80 |
Day 14 | 0.54 ±0.10 | 0.58 ±0.008 | 0.051 | |
P-value | < 0.001 | < 0.001 | ||
Thiol | Baseline | 385.91 ±157.37 | 379.80 ±17.44 | 0.08 |
Day 14 | 416.01 ±17.82 | 365.15 ±17.52 | < 0.001 | |
P-value | < 0.001 | < 0.001 | ||
TAC | Baseline | 798.92 ±17.13 | 802.96 ±13.61 | 0.21 |
Day 14 | 878.78 ±27.84 | 802.83 ±14.58 | < 0.001 | |
P-value | < 0.001 | 0.9 |
MDA – malondialdehyde, TAC – total antioxidant capacity